News
By Susan Ferrechio – The Washington Times – Saturday, November 18, 2023
11-18-23
The company NewsGuard, which ranks news sites to counter what it deems misinformation, including stories that question COVID-19 vaccine safety and efficacy, received significant funding from a firm that represents some of the world’s biggest pharmaceutical companies.
NewsGuard’s leaders said there’s no conflict of interest. The group’s investors, they said, have never contacted them, nor do they have any influence whatsoever on the company’s rating system.
That rating system has steered advertisers from websites such as U.K.-based Daily Sceptic, which emerged during the pandemic to challenged lockdowns, mandates and vaccine safety and efficacy, the natural health site Mercola and the conservative-leaning Federalist, which raised questions about mask mandates, among many other news outlets.
Journalists whose sites have been downgraded by NewsGuard say the for-profit company is working to censor news outlets that produce content opposed by NewsGuard’s paying clients.
Read the full article here: Big Pharma financing NewsGuard’s for-profit business monitoring news truthfulness – Washington Times
